MacroGenics Short Term Investments vs Long Term Investments Analysis

MGNX Stock  USD 3.34  0.14  4.02%   
MacroGenics financial indicator trend analysis is infinitely more than just investigating MacroGenics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MacroGenics is a good investment. Please check the relationship between MacroGenics Short Term Investments and its Long Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Short Term Investments vs Long Term Investments

Short Term Investments vs Long Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MacroGenics Short Term Investments account and Long Term Investments. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between MacroGenics' Short Term Investments and Long Term Investments is -0.25. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Long Term Investments in the same time period over historical financial statements of MacroGenics, assuming nothing else is changed. The correlation between historical values of MacroGenics' Short Term Investments and Long Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of MacroGenics are associated (or correlated) with its Long Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Investments has no effect on the direction of Short Term Investments i.e., MacroGenics' Short Term Investments and Long Term Investments go up and down completely randomly.

Correlation Coefficient

-0.25
Relationship DirectionNegative 
Relationship StrengthInsignificant

Short Term Investments

Short Term Investments is an item under the current assets section of MacroGenics balance sheet. It contains any investments MacroGenics undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that MacroGenics can easily liquidate in the marketplace.

Long Term Investments

Long Term Investments is an item on the asset side of MacroGenics balance sheet that represents investments MacroGenics intends to hold for over a year. MacroGenics long term investments may include different instruments such as stocks, bonds, real estate and cash.
Most indicators from MacroGenics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MacroGenics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.At this time, MacroGenics' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 275.27 in 2024, whereas Selling General Administrative is likely to drop slightly above 37 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses275.8M266.0M217.2M181.0M
Cost Of Revenue2.7M7.4M8.2M7.8M

MacroGenics fundamental ratios Correlations

0.310.380.97-0.240.78-0.33-0.58-0.53-0.130.740.80.410.220.950.390.810.740.080.520.760.210.520.99-0.280.84
0.310.30.240.150.320.010.01-0.280.20.070.330.130.080.250.210.160.50.230.20.30.310.250.29-1.00.16
0.380.30.20.010.670.24-0.02-0.670.640.170.670.380.610.160.450.540.670.290.680.660.70.680.27-0.280.54
0.970.240.2-0.390.62-0.5-0.66-0.33-0.220.780.680.430.190.980.230.680.56-0.120.450.59-0.040.370.98-0.210.71
-0.240.150.01-0.390.10.640.36-0.33-0.14-0.23-0.12-0.73-0.46-0.310.37-0.020.090.84-0.430.060.560.24-0.25-0.16-0.05
0.780.320.670.620.10.15-0.35-0.72-0.040.540.950.310.140.560.750.820.840.410.460.840.650.580.68-0.290.83
-0.330.010.24-0.50.640.150.45-0.360.23-0.380.01-0.46-0.02-0.540.670.040.180.58-0.050.180.62-0.05-0.39-0.010.04
-0.580.01-0.02-0.660.36-0.350.45-0.20.43-0.93-0.31-0.180.04-0.63-0.12-0.22-0.050.42-0.05-0.080.270.06-0.61-0.02-0.25
-0.53-0.28-0.67-0.33-0.33-0.72-0.36-0.2-0.3-0.12-0.72-0.22-0.34-0.31-0.62-0.83-0.89-0.75-0.63-0.91-0.81-0.82-0.440.25-0.83
-0.130.20.64-0.22-0.14-0.040.230.43-0.3-0.380.060.310.69-0.22-0.040.020.220.040.580.20.330.28-0.17-0.20.02
0.740.070.170.78-0.230.54-0.38-0.93-0.12-0.380.510.260.00.740.270.450.29-0.140.220.32-0.080.230.76-0.050.48
0.80.330.670.68-0.120.950.01-0.31-0.720.060.510.560.250.590.660.830.850.280.620.850.540.570.7-0.30.85
0.410.130.380.43-0.730.31-0.46-0.18-0.220.310.260.560.430.32-0.050.350.35-0.310.70.36-0.040.220.34-0.110.38
0.220.080.610.19-0.460.14-0.020.04-0.340.690.00.250.430.16-0.020.330.38-0.210.770.40.140.380.2-0.070.35
0.950.250.160.98-0.310.56-0.54-0.63-0.31-0.220.740.590.320.160.130.660.54-0.070.380.56-0.030.420.98-0.230.68
0.390.210.450.230.370.750.67-0.12-0.62-0.040.270.66-0.05-0.020.130.550.620.520.280.630.660.20.3-0.190.58
0.810.160.540.68-0.020.820.04-0.22-0.830.020.450.830.350.330.660.550.910.40.640.960.590.670.76-0.130.99
0.740.50.670.560.090.840.18-0.05-0.890.220.290.850.350.380.540.620.910.510.680.970.730.690.66-0.480.91
0.080.230.29-0.120.840.410.580.42-0.750.04-0.140.28-0.31-0.21-0.070.520.40.510.020.490.780.590.03-0.230.38
0.520.20.680.45-0.430.46-0.05-0.05-0.630.580.220.620.70.770.380.280.640.680.020.710.320.520.46-0.180.67
0.760.30.660.590.060.840.18-0.08-0.910.20.320.850.360.40.560.630.960.970.490.710.720.70.69-0.280.96
0.210.310.7-0.040.560.650.620.27-0.810.33-0.080.54-0.040.14-0.030.660.590.730.780.320.720.590.11-0.30.56
0.520.250.680.370.240.58-0.050.06-0.820.280.230.570.220.380.420.20.670.690.590.520.70.590.47-0.220.66
0.990.290.270.98-0.250.68-0.39-0.61-0.44-0.170.760.70.340.20.980.30.760.660.030.460.690.110.47-0.260.78
-0.28-1.0-0.28-0.21-0.16-0.29-0.01-0.020.25-0.2-0.05-0.3-0.11-0.07-0.23-0.19-0.13-0.48-0.23-0.18-0.28-0.3-0.22-0.26-0.13
0.840.160.540.71-0.050.830.04-0.25-0.830.020.480.850.380.350.680.580.990.910.380.670.960.560.660.78-0.13
Click cells to compare fundamentals

MacroGenics Account Relationship Matchups

MacroGenics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets312.5M378.7M335.2M280.5M298.4M287.5M
Other Current Liab27.1M26.2M24.4M19.5M24.2M25.5M
Total Current Liabilities45.2M50.7M74.6M48.6M56.1M47.8M
Total Stockholder Equity230.6M295.9M239.6M142.0M152.6M199.6M
Other Liab9.2M6.9M258K59.7M53.8M56.5M
Property Plant And Equipment Net48.2M42.2M37.7M56.9M45.7M32.9M
Current Deferred Revenue10.7M11.4M20.6M69.5M21.7M22.3M
Net Debt(95.9M)(151.9M)(98.0M)(74.1M)(67.0M)(70.3M)
Retained Earnings(642.1M)(771.8M)(973.9M)(1.1B)(1.1B)(1.0B)
Accounts Payable4.3M8.0M15.5M4.9M6.4M6.1M
Cash126.5M181.1M123.5M108.9M101.0M146.4M
Non Current Assets Total72.7M66.1M55.7M58.3M47.1M40.8M
Non Currrent Assets Other24.5M23.9M18.0M(7.7M)1.4M1.3M
Other Assets4.3M23.9M335.2M1.4M1.00.95
Cash And Short Term Investments215.8M272.5M243.6M154.3M229.8M224.7M
Net Receivables12.7M23.1M10.4M56.2M10.4M14.4M
Common Stock Total Equity490K562K613K617K709.6K396.0K
Common Stock Shares Outstanding48.1M52.4M59.9M61.4M61.9M42.1M
Liabilities And Stockholders Equity312.5M378.7M335.2M280.5M298.4M287.5M
Non Current Liabilities Total36.7M32.2M21.0M89.8M89.7M94.2M
Other Current Assets11.3M34.0M42.3M10.2M9.9M11.0M
Other Stockholder Equity872.2M1.1B1.2B1.2B1.3B774.0M
Total Liab81.9M82.9M95.6M138.5M145.8M87.9M
Property Plant And Equipment Gross48.2M42.2M110.5M29.6M134.1M140.8M
Total Current Assets239.8M312.6M279.6M222.2M251.3M246.7M
Accumulated Other Comprehensive Income(61K)(3K)16K(7K)(6K)(6.3K)
Short Term Debt3.0M8.0M9.4M9.5M3.8M3.6M
Common Stock490K562K613K617K621K418.1K
Property Plant Equipment68.4M42.2M37.7M29.6M34.0M30.8M
Net Tangible Assets230.6M295.9M239.6M142.0M163.3M245.6M
Short Term Investments89.3M91.4M120.1M45.5M128.8M91.7M
Capital Surpluse872.2M1.1B1.2B1.2B1.4B817.2M
Deferred Long Term Liab24.9M29.3M6.9M59.5M68.4M71.8M
Net Invested Capital230.6M295.9M239.6M142.0M152.6M183.2M
Net Working Capital194.6M261.9M205.0M173.6M195.2M172.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.